chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The moment the vaccine was injected, patient went into a tight muscle cry. Patient cried on and off for 24 hours. She was not able to stand on her right leg. She just held it up out of natural reflexes. The next morning patient had a rash on her body from head to toe. I bought her back and she was diagnosed with eczema.  When patient would eat eggs, dairy, or oranges the eczema would flair. The treatment is oatmeal baths, cocoa butter, Shea butter,and avoid anything that is processed. This lasted for 18 months and slowly could reintroduce foods. I know when she is going to be sick, because her skin will flair because her immune system is warning me.  The most that came from this, is for parents to research Vaccines. After going to specialist about her condition, she was diagnosed with MTHFR. Her liver cannot detox well. Which makes since why she had such a reaction. There is always a silver lining.
About 7 - 8 days after the vaccination, the patient began experiencing numbness in his chin that came and went. By Friday, April 2, the patient began experiencing left side numbness and droopiness in his face, had slurred speech and increased blood pressure. Patient thought he was having a stroke, so wife took him to the ER. All lab work and medical tests came back normal. The patient has an appointment with their family doctor on 4/8 and an appointment with a neurologist next month.
Patient contracted COVID after being fully vaccinated runny nose, headache, sore throat, congestion, fatigue Patient is now pregnant
Within 30 minutes, post vax, she felt sleepy, left arm pain and sweaty. On 11/2/00, temperature was 99.2F, injection still warm with induration, reddened, site sore, arm sore and still tired and sweats.
Expired dose administered to newborn; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a neonate female patient who received HBV (Engerix B pediatric) for prophylaxis.   On 17th June 2022, the patient received Engerix B pediatric. On 17th June 2022, unknown after receiving Engerix B pediatric, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: SK Receipt Date: 17-Jun-2022 Reporter's comments: An expired dose of Engerix-B administered to newborn patient. The consent to follow up was given. Expiration date, lot number, and initials were unavailable at the time of reporting.  Additional Supportive Information: An expired dose of Engerix-B administered to newborn patient, which led to expired vaccine used.
had a shot in 2020 February 2021 I got the shingles/ suspected vaccination failure; I got the shingles; This case was reported by a consumer via media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In February 2021, more than a year after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the consumer. The age at vaccination was not reported. The reporter stated that, in 2020 received shot and in February 2021, had shingles. The reporter stated that, in July 2021, was still dealing with shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles and laboratory confirmation for shingles were not provided.
More severe: Low back pain starting 06:40 AM Thursday June 10, continuing into present. Made same-day appointment with clinic. Tests normal. Mild to moderate: Site soreness (no redness swelling) starting June 7 continuing to present (6.5 days at present).
Paresthesia L Arm lasting out to 10/11/12, presently c/o of same to L leg. Able to use all extremities, no resp complaints or other neuropathies. Same complaint stated by patient last year after injection, denies further complications.
Information has been received from a nurse practitioner concerning a 20 year old female patient who on 27-AUG-2009 was vaccinated with the first of GARDASIL, lot # 0670Y. On 03-SEP-2009 the patient developed a size of a dime insect bite like appearance on the injection site, it was also reported that the injection site was hot and hard to the touch with no swelling; however, the patient had tingling in her hand and her entire arm where she had the injection was achy. Nurse practitioner noted that there was no systemic problem. The patient sought medical attention by calling the nurse practitioner. Follow up information was received from the nurse practitioner indicating that the patient was vaccinated in the left deltoid, intramuscularly, at 2 pm. Concomitant therapy included ORTHO TRI-CYCLEN. Nurse reported that on 03-SEP-2009 the patient presented with complaints of swelling at the injection site, heaty, arm achy with tingling in fingers and left hand. Additionally, nurse reported that the patient was treated with OTC (antiinflammatory) and was given ice to area as tolerated. No further information is available.
Because of the Covid epidemic, I just got my 2nd./time between shots was 2 years.; This case was reported by a consumer via interactive digital media and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows:  The patient had reported the case for himself/herself. The age at vaccination was not reported. Because of the Covid epidemic, the patient just got 2nd Shingrix shot but the time between shots was 2 years. The patient enquired if he/she need another shot in 4 to 6 months.
had pelvic pain; spotting; This is a spontaneous report from a contactable consumer or other non-health care professional (patient) via Pfizer sponsored program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as dose1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, exactly 10 days after vaccine administration, the patient experienced pelvic pain and spotting. She stated this was not normal for her and she wants to speak to someone about side effects. Case assessed as non-serious by reporter. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
vaccine was administered and patient lost consciousness. he began to turn red and did not breathe for several seconds at which we were about to administer an EpiPen. He then took a breath and started to convulse. he regained consciousness and was not coherent at first. He was sweaty and pale. Pt became alert and oriented and stayed in the room while we waited for the emt to arrive. He declined to be taken to the hospital. He moved to the waiting room and was monitored for 30 minutes before leaving
Her sinuses start draining as well; tongue and throat swelling; tongue and throat swelling; This is a spontaneous report from a contactable pharmacist from a Pfizer sponsored program. A 64-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0176; Expiration Date: 31Aug2021), dose 1 via an unspecified route of administration, administered in Deltoid Right on 17May2021 16:00(Age at vaccination 64 years) as 1st dose, 0.3 ml single dose for covid-19 immunisation. Medical history included Pre-diabetic, Hypothyroidism (It is medically induced hypothyroidism), lymphoedema, disabled with back injury , She is allergic to other medications. Concomitant medications included syntroid (LEVOTHYROXINE SODIUM) aminobenzoic acid, ascorbic acid, betaine hydrochloride, bioflavonoids nos, biotin, calcium, calcium pantothenate, choline bitartrate, colecalciferol, copper, cyanocobalamin, folic acid, glutamic acid, hesperidin, inositol, iodine, iron, magnesium, manganese, nicotinamide, potassium, pyridoxine hydrochloride, retinol palmitate, riboflavin, rutoside, thiamine mononitrate, tocopheryl acetate, zinc (MULTIVITAMIN N) cranberry (CRANBERRY) taken for urinary tract infection. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 15 to 20 min after vaccine application the patient experienced tongue and throat swelling, her sinuses start draining as well on an unspecified date. That morning, she had taken an over the counter antihistamine and was thinking that is probably what stopped the reaction. that is her typical response when faced with something she is allergic to. She is allergic to other medications, medication she took was generic Claritin She does not remember the dose or anything else. When she looked at the CDC information on medications to find out, she did not recognize any of the meds and thought she would be safe. The patient underwent lab tests and procedures which included blood test found synthroid increased (Had bloodwork done, before the vaccine and they had just increased her dose of Synthroid over a month ago). Patient had no medications or treatments after the event occurred. The outcome of events tongue and throat swelling was recovered 10 to 15 minutes on 17May2021 . sinuses start draining outcome was unknown.  Patient states that it is okay to contact her later and that her physician does not know about this. She has not contacted them yet but will see in a week or so.
Fever, chills, body aches, headache, diarrhea, dizzy, shallow breathing, shortness of breath.  Had to increase my oxygen level 2%. Took Tylenol with little help.
Approximately 10 minutes after vaccination,(2:20 PM on 12/2/21)  patient began experiencing lip tingling and tongue began to feel numb.  2:35 PM Dr. notified and checked patient,  MD ordered Benadryl 50 mg  which was given at 2:38 PM orally.  2:48 PM patient notes tongue still feels swollen but is feeling better, 2:55 PM vital signs taken - breathing fine, feeling like tongue is less swollen. Lips are not tingling.  T 97.2, BP 119/68, P-72, R-16, 02 97% r/a. 3:00 PM DR.  advised patient to wait an additional 20 minutes.  3:15 PM patient feeling a little better, though sleepy.  3:20 Vital signs taken:  R -20, 02 96% on ra, P-71, BP 119/72.  Tongue less swollen, feeling sleepy.  Patient was allowed to go home, accompanied by mother who will drive them.  Encouraged to call back if further problems.  Patient was contacted the following day and states she is doing OK.  Per Dr. advice, patient instructed to be sure to take 50 mg Benadryl PO 1/2 hour prior to coming in for second Moderna vaccination.
This spontaneous report as received from a health care worker refers to a 12 year old female patient, who is also the healthcare worker's daughter. The patient's medical history included brain cancer currently in remission. On 05-AUG-2013 the patient was vaccinated with GARDASIL dose 1, intramuscular in the left arm. Other suspect therapies included VAQTA (unspecified dose and frequency). Concomitant medication were not provided. On 07-AUG-2013, the patient experienced tingling sensations down the entire left side of her body that lasted for 5 days, weird feeling in throat, painful migraines and metallic taste in mouth. The tingling sensation stopped for five days, but then started again and persisted for another three days. A brain MRI was scheduled for an unspecified date. No treatment was given. The outcome of tingling sensations down the entire left side of her body that lasted for 5 days off and on, weird feeling in throat, painful migraines and metallic taste in mouth was not provided. Additional information has been requested.
Vaccine - Influenza, received on 11/05/15; pt developed pain in RUE. The next day she developed swelling in the underarm area of the RUE, associated with soreness.
Blood clot in subclavian vein, had a veinogram, placed on blood thinners, had to have first rib removed, blood clot in lung.
When patient works out he breaks out in rash all over body. Develops hives on top of hives. Very itchy.
10 minutes after patient received the vaccine he became diaphoretic and lightheaded. Blood pressure 90/60 HR 53 Oxygen Saturation 97%.  Patient was placed in the clinic chair with his legs elevated, patient was given water. EMS called to clinic, patient declined to go to the ER stated he was feeling better. Patient left the store  accompanied by his 14 year old son.
Patient has experienced worsening generalized urticaria and arthralgias, fatigue 48 hours after her vaccination. This is a chronic longstanding issue for her already but has worsened, and patient is unsure if she should get the second dose of pfizer. She did not experience any anaphylaxis symptoms.
pt apporached pharmacy 9/19 @2:25 pm, she states her arm has a red rash after an injection. Redness is about 4 inches in all directions from injection site, pt states she experienced headache and fever for about 18 hours post immunization starting 2 hours post injection. Pulled release form and found left arm to be site of shingrix injection, no other raised rash anywhere on her body other than surrounding injection site. Explained to pt that the redness at injection site is normal also fever and soreness normal per VIS.
major fatigue, soreness of arm at injection site,  headache next day: headache, fatigue, nausea, aches and chills, feeling of being very 'bruisable'  It's now about 25 hours after my shot and I am feeling quite a bit better, but still tired, and my arm is still pretty sore
This spontaneous report as received from a physician via a company representative refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 (intravenously; dose, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient experienced lump at the injection site. In March 2017 (reported as lasts 1-3 weeks), the patient experienced painful swelling at the injection site. The outcome of the adverse events was unknown. The relatedness between lump and painful swelling at the injection site and GARDASIL 9 was not provided. Additional information is not expected as the reporter did not wish to be contacted.
Spoke to mom on 09/25/2003 states pt had red, swollen area that was warm to touch with fever noted, from DTAP site on increased left deltoid.  Noted that on 09/23/03 on 09/24/03 swelling progressed to elbow and was red and swollen.  Mom called MD was will start on Augmentin today.  Mom did not see MD-only telephone call.  States started Augmentin for "cellulitis" of left arm.
Within 15 minutes of the shot I was dizzy, had numbness in my extremities, tingling in my hands and feet.  Since the vaccine I've stayed constantly exhausted, confused, random but regular bouts of pins and needle sensation, and I randomly lose my grip on what I'm holding.
ACUTE RESPIRATORY FAILURE CHRONIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE
seizure with a fever spike of 102; seizure with a fever spike of 102; very tired; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 9 year-old male patient received BNT162B2 (BNT162B2), administered in arm left, administration date 05Jan2022 16:00 (Lot number: FKS189) at the age of 9 years as dose 1 (tris), single for covid-19 immunisation. Relevant medical history included: "Febrile seizures almost 5yrs ago" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing); "known allergies: berries" (unspecified if ongoing). Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021 at 21:00 and 07Jan2021, the patient complained of being very tired. On 07Jan2021 at 21:00, he had a seizure with a fever spike of 102, and then a hospital visit. The events "seizure with a fever spike of 102" and "very tired" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: body temperature: (07Jan2022) 102; sars-cov-2 test: (07Jan2022) pending. It was unknown if therapeutic measures were taken as a result of seizure, fatigue, pyrexia. The outcome of the events was resolving.  No follow-up attempts are possible. No further information is expected.
Next day I have fever and rashes all over my body and transform in to big hives the side of a orange huge I still experienced hives all over this
2/19/08 Pt states had 6 cm in redness and 4 cm induration at injection site 24 hours after she had the injection.  There was no induration, but slight redness at the site when seen today.
Myalgia, NauseaVomiting, back pain Narrative:  treated at ER on 1/21/21 with steroid injection & NSAID injection, sent home on Naproxen 500mg & Robaxin 500mg  Other Relevant History:
Enlarged lymph node in armpit of arm shot was given; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported.  On 01Mar2021, the patient experienced enlarged lymph node in armpit of arm shot was given. Therapeutic measures were not taken as a result of the events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph node in armpit of arm shot was given was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
9-13-16 Doctor appt. - within hours patient had some stomach discomfort that got worse over the week. She had the stroke on 9/20/16. The stroke in the patient's brain was inoperable, in coma for a while, 6 weeks and 4 days later death.
Just under 3 weeks after last dose, development of left popliteal/distal femoral vein deep venous thrombosis with several small bilateral pulmonary emboli.   Symptoms were about 4 days of increasing discomfort left calf, edema, pain in region of left gastrocnemius muscle, depend erythema, all not responsive to NSAIDS.   I was hospitalized overnight for assessment and treatment.  Started on heparin, switched to Eliquis.  So far, no complications.
Patient presented to clinic with redness, pain and swelling.  She was seen by her primary care provider  who prescribed antibiotics and advised to alternate 20 min heat with 20 min ice.
Vaccine was given too high in the left upper arm. Injection of vaccine went into the shoulder capsule and NOT the deltoid. Person receiving the vaccine is a nurse and also provides vaccine administration education to medical staff at Covid vaccine sites; thus is aware of proper technique and was able to identify the Tdap vaccine was not given properly at the time of administration. Side effects started the following day with a sore upper arm, then quickly progressed to diffused shoulder, neck, upper back, chest pain that developed into burning, tingling and numbing sensations from the ;eft, upper arm down to the elbow, then into the hand. Symptoms continue to worsen at greater than 3 weeks post immunization and indicate SIRVA and brachial neuritis. Currently under medical care for these symptoms. No relief or improvement has occurred to date.
pt transferred from outside facility to hospital with admission dx of COVID PNA; treated with Barcintinib, steroids, remdesivir; progressive hypoxemia and multiorgan failure; pt progressively deteriorated; comfort care measures; pt died in the hospital
Pt. states that after receiving the 1st dose of Phizer 02/22/2021, started experiencing symptoms immediately of face numbness and tongue swelling. Treated with Benadryl (home). Continuing for 7-10 days. Primary communications (phone), Informed through recommendations to not receive the 2nd dose of Phizer.
Initial report received on 18 July 2012 from the Investigator participating in the post-marketing study under the reference number M5A16. A case of pertussis disease in a two-year-old male subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) database. The subject had received 4 doses of PENTACEL on the following dates: 18 September 2009, 20 November 2009, 29 January 2010 and 03 November 2010 (lot numbers, routes and sites of administration not reported). The subject developed cold-like symptoms on 28 May 2012, approximately one year and seven months after the last dose. On 04 June 2012, the subject developed a paroxysmal cough with a whoop. Laboratory testing included positive PCR on 08 June 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 09 June 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 25 June 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 21 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.